Sort
50,496 grants matching “lung cancer”
Prediction Model: Breast Cancer in Women Irradiated for a Pediatric Malignancy
$383,840Chaya Moskowitz · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
MicroRNA Therapy for Lymph Node Metastatic Breast Cancer
$383,839Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2014 · CA
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
$383,831Adam Joel Bass · Dana-Farber Cancer Inst · R01 · FY2015 · CA
DDR2 kinase inhibition in squamous cell lung carcinomas
$383,814Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2014 · CA
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
$383,750Ruslan Rafikov · University Of Arizona · R01 · FY2016 · HL
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$383,750Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2023 · CA
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
$383,750Ruslan Rafikov · University Of Arizona · R01 · FY2019 · HL
Signal transduction mechanisms that mediate normal and pathologic angiogenesis
$383,750Jinjiang Pang · University Of Rochester · R01 · FY2016 · HL
Contribution of Notch signaling to vascular remodeling
$383,750Lucy Liaw · Mainehealth · R01 · FY2016 · HL
Signal transduction mechanisms that mediate normal and pathologic angiogenesis
$383,750Jinjiang Pang · University Of Rochester · R01 · FY2014 · HL
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
$383,750Ruslan Rafikov · University Of Arizona · R01 · FY2017 · HL
Contribution of Notch signaling to vascular remodeling
$383,750Lucy Liaw · Mainehealth · R01 · FY2017 · HL
Signal transduction mechanisms that mediate normal and pathologic angiogenesis
$383,750Jinjiang Pang · University Of Rochester · R01 · FY2017 · HL
Roles of mechanotransduction in organ regeneration and fibrosis
$383,750Zhipeng Meng · University Of Miami School Of Medicine · R35 · FY2021 · GM
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
$383,750Ruslan Rafikov · University Of Arizona · R01 · FY2020 · HL
Roles of mechanotransduction in organ regeneration and fibrosis
$383,750Zhipeng Meng · University Of Miami School Of Medicine · R35 · FY2024 · GM
Roles of mechanotransduction in organ regeneration and fibrosis
$383,750Zhipeng Meng · University Of Miami School Of Medicine · R35 · FY2025 · GM
UNDERSTANDING AND BLOCKING METABOLIC DEGLYCATION IN LUNG CANCER
$383,750The Trustees Of Columbia University In The City Of New York · · FY2021 · Defense Health Agency
Contribution of Notch signaling to vascular remodeling
$383,750Lucy Liaw · Mainehealth · R01 · FY2014 · HL
Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
$383,750Taslim A Al-Hilal · University Of Texas El Paso · SC1 · FY2023 · GM
Roles of mechanotransduction in organ regeneration and fibrosis
$383,750Zhipeng Meng · University Of Miami School Of Medicine · R35 · FY2022 · GM
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension.
$383,750Ruslan Rafikov · University Of Arizona · R01 · FY2018 · HL
Signal transduction mechanisms that mediate normal and pathologic angiogenesis
$383,750Jinjiang Pang · University Of Rochester · R01 · FY2018 · HL
Roles of mechanotransduction in organ regeneration and fibrosis
$383,750Zhipeng Meng · University Of Miami School Of Medicine · R35 · FY2023 · GM
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
$383,749Shyam Biswal · Johns Hopkins University · R01 · FY2019 · CA